Intensifying Antiretroviral Therapy With Raltegravir and Maraviroc During Early Human Immunodeficiency Virus (HIV) Infection Does Not Accelerate HIV Reservoir Reduction

Background. Persistent human immunodeficiency virus (HIV) within the CD4(+) T-cell reservoir is an obstacle to eradication. We hypothesized that adding raltegravir and maraviroc to standard combination antiretroviral therapy (cART) during early HIV infection could substantially reduce viral reservoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostrowski, Mario, Benko, Erika, Yue, Feng Yun, Kim, Connie J., Huibner, Sanja, Lee, Terry, Singer, Joel, Pankovich, Jim, Laeyendecker, Oliver, Kaul, Rupert, Kandel, Gabor, Kovacs, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621663/
https://www.ncbi.nlm.nih.gov/pubmed/26512359
http://dx.doi.org/10.1093/ofid/ofv138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621663/
https://www.ncbi.nlm.nih.gov/pubmed/26512359
http://dx.doi.org/10.1093/ofid/ofv138

Ejemplares similares